Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004704
Filing Date
2019-05-09
Accepted
2019-05-09 16:38:22
Documents
79
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20190331x10q.htm 10-Q 1811498
2 EX-10.1 osmt-20190331ex101dcda31.htm EX-10.1 187851
3 EX-31.1 osmt-20190331ex311da1206.htm EX-31.1 12653
4 EX-31.2 osmt-20190331ex3129e5d23.htm EX-31.2 12622
5 EX-32.1 osmt-20190331ex32135e796.htm EX-32.1 10162
6 EX-32.2 osmt-20190331ex322edc406.htm EX-32.2 11250
  Complete submission text file 0001558370-19-004704.txt   7873476

Data Files

Seq Description Document Type Size
7 EX-101.INS osmt-20190331.xml EX-101.INS 1819061
8 EX-101.SCH osmt-20190331.xsd EX-101.SCH 51989
9 EX-101.CAL osmt-20190331_cal.xml EX-101.CAL 77688
10 EX-101.DEF osmt-20190331_def.xml EX-101.DEF 179681
11 EX-101.LAB osmt-20190331_lab.xml EX-101.LAB 464793
12 EX-101.PRE osmt-20190331_pre.xml EX-101.PRE 362005
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 19811215
SIC: 2834 Pharmaceutical Preparations